Related Experiment Video
Updated: Aug 18, 2025

Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
ARH Family of ADP-Ribose-Acceptor Hydrolases
Hiroko Ishiwata-Endo1, Jiro Kato1, Sachiko Yamashita1
1Laboratory of Translational Research, Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Insights
The ADP-ribose-acceptor hydrolase (ARH) family, including ARH1 and ARH3, plays crucial roles in cellular processes. ARH1 deficiency leads to tumors and cardiac issues, while ARH3 deficiency causes neurodegeneration and cell death via Parthanatos.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- The ADP-ribose-acceptor hydrolase (ARH) family comprises three members (ARH1-3) with sequence similarities.
- ARH1 was identified by its ability to hydrolyze ADP-ribosyl-arginine, a product of cholera toxin and mammalian ADP-ribosyltransferases (ARTCs).
- ARH3 cleaves ADP-ribose from poly(ADP-ribose) (PAR) chains and hydrolyzes NAD+ and O-acetyl-ADP-ribose.
Purpose of the Study:
- To investigate the enzymatic activities and biological functions of the ARH family members.
- To elucidate the roles of ARH1 and ARH3 in cellular processes and disease models.
- To explore the therapeutic potential of PARP inhibitors in ARH3-deficient conditions.
Main Methods:
- In vitro enzymatic assays to determine substrate specificity of ARH1 and ARH3.
- Generation and analysis of Arh1 and Arh3 knockout (KO) mouse models.
- Cellular assays involving H2O2 treatment and PARP activation in Arh3-KO cells.
- Assessment of cardiac function, tumor development, and neurological phenotypes in KO mice.
Main Results:
- Arh1-KO mice developed tumors, decreased cardiac contractility, and myocardial fibrosis, with increased ADP-ribosylation of TRIM72.
- Arh3-KO cells exhibited increased PARP-1 activation, leading to cell death by Parthanatos upon H2O2 treatment.
- Human ARH3 deficiency is linked to neurodegeneration and early death; Arh3-KO mice showed increased brain infarction, mitigated by PARP inhibitors.
Conclusions:
- The ARH family possesses distinct enzymatic activities and critical roles in biological processes.
- ARH1 is involved in preventing tumor formation and maintaining cardiac function.
- ARH3 plays a vital role in cellular defense against oxidative stress and preventing neurodegeneration, with therapeutic implications for PARP inhibition.
Abstract:
The ARH family of ADP-ribose-acceptor hydrolases consists of three 39-kDa members (ARH1-3), with similarities in amino acid sequence. ARH1 was identified based on its ability to cleave ADP-ribosyl-arginine synthesized by cholera toxin. Mammalian ADP-ribosyltransferases (ARTCs) mimicked the toxin reaction, with ARTC1 catalyzing the synthesis of ADP-ribosyl-arginine. ADP-ribosylation of arginine was stereospecific, with β-NAD+ as substrate and, α-anomeric ADP-ribose-arginine the reaction product. ARH1 hydrolyzed α-ADP-ribose-arginine, in addition to α-NAD+ and O-acetyl-ADP-ribose. Thus, ADP-ribose attached to oxygen-containing or nitrogen-containing functional groups was a substrate. Arh1 heterozygous and knockout (KO) mice developed tumors. Arh1-KO mice showed decreased cardiac contractility and developed myocardial fibrosis. In addition to Arh1-KO mice showed increased ADP-ribosylation of tripartite motif-containing protein 72 (TRIM72), a membrane-repair protein. ARH3 cleaved ADP-ribose from ends of the poly(ADP-ribose) (PAR) chain and released the terminal ADP-ribose attached to (serine)protein. ARH3 also hydrolyzed α-NAD+ and O-acetyl-ADP-ribose. Incubation of Arh3-KO cells with H2O2 resulted in activation of poly-ADP-ribose polymerase (PARP)-1, followed by increased nuclear PAR, increased cytoplasmic PAR, leading to release of Apoptosis Inducing Factor (AIF) from mitochondria. AIF, following nuclear translocation, stimulated endonucleases, resulting in cell death by Parthanatos. Human ARH3-deficiency is autosomal recessive, rare, and characterized by neurodegeneration and early death. Arh3-KO mice developed increased brain infarction following ischemia-reperfusion injury, which was reduced by PARP inhibitors. Similarly, PARP inhibitors improved survival of Arh3-KO cells treated with H2O2. ARH2 protein did not show activity in the in vitro assays described above for ARH1 and ARH3. ARH2 has a restricted tissue distribution, with primary involvement of cardiac and skeletal muscle. Overall, the ARH family has unique functions in biological processes and different enzymatic activities.
More Related Videos
08:17A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
Published on: April 16, 2021
09:07Single-Step Enrichment of a TAP-Tagged Histone Deacetylase of the Filamentous Fungus Aspergillus nidulans for Enzymatic Activity Assay
Published on: May 1, 2019
Related Concept Videos
Export of Misfolded Proteins out of the ER
Hydrolysis of ATP
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine...
Lysosomal Hydrolases
Surface Appendages of Archaea
The ADP/ATP Carrier Protein
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...